Studies have shown that AD patients with the PON-1 gene carrying the R allele are more susceptible to treatment with acetylcholinesterase inhibitors than AD patients with the QQ allele (Pola et al., 2005). This evidence concerns the gene PON1 and Alzheimer disease.